Clinical features and outcomes of MEN2A with RET codon 634 pathogenic variants
Journal of the Endocrine Society · 02.11.2026 · 10 (12)
DOI: 10.1210/jendso/bvag254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Endocrine Society, online erschienen am 31.10.2026. Verfasst von Sarah Hamidi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Exelixis, Eli Lilly & Co.
Abstract (Originalsprache)
Background
Germline RET codon 634 pathogenic variants (PVs) are at high-risk for early-onset medullary thyroid carcinoma (MTC), but prior reports suggest that RET p.C634R PV may confer a more aggressive phenotype.
Methods
We compared MEN2A phenotype and MTC outcomes with germline RET p.C634R vs other RET p.C634X PVs. We conducted a retrospective single-center cohort study of patients harboring a germline RET p.C634 PV, enrolled in the MTC Collaborative Registry (MTCCoRe) and seen at least once between May 2012 and May 2024.
Results
One hundred and thirty-five patients included: p.C634R (n = 60) and other p.C634X variants (n = 75). The p.C634R PV was associated with higher penetrance of pheochromocytoma (PHEO) (67% vs 37%, P < .001) and primary hyperparathyroidism (PHPT) (30% vs 15%, P = .036). Prevalence of MTC (87% vs 80%, P = .362), cutaneous lichen amyloidosis (17% vs 9% P = .296), and median age at initial thyroidectomy (18 vs 20 years, P = .479) did not differ significantly between groups. Medullary thyroid carcinoma characteristics, including stage, multifocality, extrathyroidal extension, vascular invasion, lymph node metastases, and distant metastases, were comparable. There were no significant differences in disease-free survival, overall survival, or distant metastasis-free survival for MTC. Disease status at last follow-up also was similar between p.C634R and other p.C634X PVs: no evidence of disease in 43% vs 62% (P = .059), biochemical evidence of disease in 25% vs 17% (P = .226), and structural evidence of disease in 27% vs 20% (P = .298).
Conclusion
In this large single-center cohort, germline RET p.C634R was associated with a higher penetrance of PHEO and PHPT but did not increase MTC aggressiveness or worsen clinical outcomes compared with other RET p.C634 PVs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Section of Endocrinology, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
- Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA.
- Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Sarah Hamidi, Steven G Waguespack, Naifa L Busaidy, Paul H Graham, Nancy D Perrier, Anita K Ying, Mimi I Hu
Förderung
- Exelixis
- Eli Lilly & Co
Zitieren
APA
Hamidi, S., Waguespack, S. G., Busaidy, N. L., Graham, P. H., Habra, M. A., Perrier, N. D., Sherman, S. I., Skefos, C. B., Sosa, J. A., Ying, A. K., Zafereo, M. E., Grubbs, E. G., & Hu, M. I. (2026). Clinical features and outcomes of MEN2A with RET codon 634 pathogenic variants. Journal of the Endocrine Society, 10(12). https://doi.org/10.1210/jendso/bvag254
Vancouver
Hamidi S, Waguespack SG, Busaidy NL, Graham PH, Habra MA, Perrier ND, et al. Clinical features and outcomes of MEN2A with RET codon 634 pathogenic variants. Journal of the Endocrine Society. 2026;10(12). doi:10.1210/jendso/bvag254
BibTeX
@article{Hamidi2026,
author = {Hamidi, Sarah and Waguespack, Steven G and Busaidy, Naifa L and Graham, Paul H and Habra, Mouhammed A and Perrier, Nancy D and Sherman, Steven I and Skefos, Catherine B and Sosa, Julie Ann and Ying, Anita K and Zafereo, Mark E and Grubbs, Elizabeth G and Hu, Mimi I},
title = {Clinical features and outcomes of MEN2A with RET codon 634 pathogenic variants},
journal = {Journal of the Endocrine Society},
year = {2026},
volume = {10},
number = {12},
doi = {10.1210/jendso/bvag254}
}
EUVIMED